These MG-Act cells were enriched in the BRAF fusion PAs compared with ANB and high-grade glioma (HGG) (scRNA data obtained from Gene Expression Omnibus [GEO] GSE249263) (Figure 3A). This evidence concerns the gene BRAF and central nervous system cancer.